EPS Bio Technology Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 146.37 million compared to TWD 125.53 million a year ago. Revenue was TWD 146.37 million compared to TWD 125.53 million a year ago. Net income was TWD 15.25 million compared to TWD 3.79 million a year ago. Basic earnings per share from continuing operations was TWD 0.64 compared to TWD 0.16 a year ago. Diluted earnings per share from continuing operations was TWD 0.64 compared to TWD 0.16 a year ago.
For the nine months, sales was TWD 359.43 million compared to TWD 333.42 million a year ago. Revenue was TWD 359.43 million compared to TWD 333.42 million a year ago. Net income was TWD 22.7 million compared to TWD 4.9 million a year ago. Basic earnings per share from continuing operations was TWD 0.95 compared to TWD 0.21 a year ago. Diluted earnings per share from continuing operations was TWD 0.95 compared to TWD 0.21 a year ago.